Outcome of Endometrial Cancer Stage IIIA with Adnexa or Serosal Involvement Only
Open Access
- 4 May 2011
- journal article
- research article
- Published by Hindawi Limited in Obstetrics and Gynecology International
- Vol. 2011, 1-7
Abstract
Objective. The aim of this study is to look at possible differences in outcome between serosa and adnexal involvement stage IIIA endometrial carcinoma. Methods. 67 patients with stage IIIA endometrial carcinoma were included, 46 with adnexal involvement and 21 with serosa. A central histopathological review was performed. Results. The 7-year locoregional failure rate was (LRFR) 2.2% for adnexal involvement and 16.0% for involvement of the serosa (𝑃=.0522). The 7-year distant metastasis-free survival was 72.7% for adnexal involvement and 58.7% for serosa (𝑃=.3994). The 7-year disease-specific survival (DSS) was 71.8% for patients with adnexal involvement and 75.4% for patients with serosa. Conclusion. Endometrial carcinoma stage IIIA with involvement of the adnexa or serosa showed to have a comparable disease-specific survival. Locoregional control was worse for serosa involvement compared to adnexa.Keywords
This publication has 17 references indexed in Scilit:
- The number of metastatic sites for stage IIIA endometrial carcinoma, endometrioid cell type, is a strong negative prognostic factorGynecologic Oncology, 2010
- The prognostic significance of positive peritoneal cytology and adnexal/serosal metastasis in stage IIIA endometrial cancerGynecologic Oncology, 2007
- Randomized Phase III Trial of Whole-Abdominal Irradiation Versus Doxorubicin and Cisplatin Chemotherapy in Advanced Endometrial Carcinoma: A Gynecologic Oncology Group StudyJournal of Clinical Oncology, 2006
- Practice patterns of SGO members for stage IIIA endometrial cancerGynecologic Oncology, 2005
- Outcome of Endometrial Carcinoma Patients with Involvement of the Uterine SerosaGynecologic Oncology, 2001
- Ovarian Metastasis in Endometrial CarcinomaGynecologic Oncology, 1998
- The Effect of Postsurgical Therapy on Stage III Endometrial CarcinomaGynecologic Oncology, 1996
- Positive peritoneal cytology is an adverse factor in endometrial carcinoma only if there is other evidence of extrauterine diseaseGynecologic Oncology, 1992
- Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: A gynecologic oncology group studyGynecologic Oncology, 1991
- Stage III adenocarcinoma of the endometrium: Two prognostic groupsGynecologic Oncology, 1980